MAJOR PRICE DROP! CHEAPEST WEGOVY IN THE UK – NO SUBSCRIPTIONS – NO TIE INS – OVER THOUSANDS OF HAPPY PATIENTS – NOT JUST AN INTRODUCTORY DISCOUNT BUT COST EFFECTIVE TREATMENT THROUGH YOUR WHOLE WEIGHT LOSS JOURNEY
Here at Pharmacy Planet, we understand that patients will be looking for safer and more cost-friendly forms of weight loss. We have made sure to give all patients access to affordable treatment and expert advice, whether it’s about switching medications or starting Wegovy for the first time. Our team of qualified UK clinicians can point you in the right direction. No Subscriptions, No Tie-Ins, just affordable weight loss that you can trust.
the items you wish
to order
by our qualified
prescriber
to your door step
Please use the options provided to make your final selection.
Select your preferred options and see the best price
It looks like you missed filling in questions from the last consultation.Click Here to submit your response.
Weight loss Injections are used for weight management in adults having obesity with medical complications such as Type 2 Diabetes, hypertension etc. You can find Wegovy in stock at Pharmacy Planet and get it delivered at your doorstep.
You can buy Wegovy injections online, starting from as low as £80 in the UK. Complete the simple online consultation form, which will be reviewed by our prescribing team to ensure you are eligible for using Wegovy in your weight loss journey.
The cost of Wegovy can vary based on strength and package sizes. If you are using wegovy for the first time, it is advised to start with the lowest Wegovy dosage 0.25mg per week and then gradually increase the dose each month in consultation with your clinician.
Wegovy Dosage:
The price list of Wegovy with multiple doses are as follows :
Starter Dose :
Wegovy 0.25 mg - £75 per month
Intermediate Doses :
Wegovy 0.5 mg - £95 per month
Wegovy 1.0 mg - £108 per month
Wegovy 1.7 mg - £125 per month
Wegovy 2.4 mg - £145 per month
Highest dose
Wegovy 7.2 mg (2.4mg x 3 pens) - £225
The Wegovy 7.2mg is still currently being reviewed for approval by the European Medicines Agency. This reviewing process can take a number of months, meaning that this new strength of Wegovy made by Novo Nordisk will probably not be released until late 2025 or early 2026.
You can move up to the Wegovy 7.2mg strength once you have reached the 2.4mg strength and feel like the level of weight loss is no longer adequate. This can be assessed by your clinician to ensure that moving up to this dose is safe for you. You should not take the Wegovy 7.2mg dose if you have a history of severe gastrointestinal issues on the lower doses, certain pre-existing medical conditions, or if you have not followed the dosing regimen from 0.25mg upwards.
Once Novo Nordisk is able to launch the new Wegovy strength of 7.2mg, you will be able to buy Wegovy 7.2mg online in the UK via Pharmacy Planet. As long as you have had your previous strengths and no medical difficulty, our clinical team should be able to issue you with this exciting new step in your weight loss journey.
Wegovy® is popular brand of weight loss medicine. It contains Semaglutide, which is an active ingredient in Wegovy. This is used to treat Type 2 diabetes but also helps in weight loss treatment in patients suffering from obesity with a BMI higher than 30 or a BMI of 27 and over for anyone with weight related health conditions such as hypertension or type 2 diabetes. It is most effective when used alongside a balanced diet and physical exercise over a long period of time.
Wegovy prescription medication is usually recommended for individuals:
If you are looking to buy Wegovy online in the UK, you would require valid prescription provided by health care professionals. You can start taking an online consultation and answering the clinical questionnaire which will be evaluated by our prescribers to make sure you qualify for this weight loss treatment.
Wegovy (Semaglutide) acts a natural hormone - glucagon-like peptide-1 (GLP 1) targets certain areas in the brain which control the appetite and blood sugar levels in your body. It gives you a feeling of fullness and reduces food cravings resulting in reduced intake of food leading to weight loss. It is a prefilled injectable pen with 4 doses, with one dose once weekly for 4 weeks, lasting for one month of treatment.
If you are taking Wegovy for first time, you often experience changes in appetite and noticeable weight loss within the first few weeks. Studies show that an average body weight reduction of 5% within a month. Usually, the weight loss with Wegovy is steady and some may achieve significant weight loss depending on age, dosage, etc
Following the regular wegovy dosage plan is necessary to ensure medication is taken consistently to achieve effective weight loss and minimising the side effects. Starting with a lower dose of 0.25 mg for the first 4 weeks helps your body adjust with the medication. After this initial period, the dose can be increased to 0.5 mg per week or higher, depending on your response to the treatment. It would take 4 to 5 weeks to reach a "steady state," where the drug concentration in your body remains consistent. It is advisable to consult your healthcare provider before increasing the doses.
Wegovy (semaglutide) should be injected under the skin once a week on the same day, at any time of the day, before or after food intake. The recommended wegovy dose for first time users is 0.25mg per week and must slowly increase over 20 weeks to maintain dose of 2.4 mg. This would help in minimizing the side effects. Each pen contains four doses lasting for a month.
Administering the injection: Hold the Wegovy pen at a 90-degree angle against the skin, ensuring it is firmly pressed against the injection site. Press the button to deliver the medication. The injection process may take a few seconds. Once complete, remove the pen from the skin.
By choosing fleshy areas of body such as upper arms, thighs or stomach (abdomen) can help the injection to hurt less. It is advised not to inject into your muscle or vein. It is better to shift injection sites to minimize discomfort and ensure optimal absorption.
If you're still struggling to figure out where you should inject, it is better to divide the injection site into four separate sections. For each dosage you can pick one of the sections and rotate between them until all four injections have been used. Also, if you are injecting in a similar spot on the upper arm or thigh, you can insert the wegovy pen at least one finger width away from your previous injection site.
Like any medications using Wegovy causes side effects that often happens within the gastro-intestinal tract. These include nausea, Diarrhoea, Vomiting, Constipation etc. Other mild side effects can be headaches, abdominal pain, tiredness, heartburn, sore throat etc. All these side effects should disappear within few weeks on its own. If it becomes severe, then consulting your doctor or pharmacist is important.
Serious side effects such as Low blood sugar levels (type 2 diabetes), Pancreatitis, Gall bladder problems, Diabetic eye problems, Risk of thyroid cancer, etc are reported in some cases.
Some patients have medical conditions which may not be suitable for using wegovy. Other factors may include cost, availability or side effects. Also, few may prefer oral medications over injections for weight loss treatments. You can explore the other treatment options provided below which would help you finding the right medication.
Mounjaro- Both Wegovy and Mounjaro are used for weight loss treatment in the UK. Mounjaro (Trizepatide) utilises dual action performance, as GLP 1 and GIP agonist are approved for type 2 diabetes management and weight loss alike.
Ozempic– The active ingredient in Wegovy, Semaglutide, is also found in Ozempic which controls the appetite and makes you feel satiety. The main difference is Wegovy has been officially licensed for weight loss while Ozempic is approved only for type 2 diabetes patients to manage their blood glucose levels.
Saxenda– Wegovy and Saxenda are injectable pens have similar functions and side effects. But the key difference are active ingredient, frequency of dosages, etc
Orlistat- It is available in form of capsules which absorbs up to 33% less fat from your diet aiding in weight loss for obese patients.
It is common that with obesity, the body faces a number of knock-on effects from this one condition. One of these, and arguably the most detrimental, is cardiovascular health. Patients who are overweight or obese have an increased risk of heart-related issues, like heart attacks, strokes and are at risk of dying early.
Wegovy encourages weight loss, which lowers blood sugar, LDL cholesterol, and high blood pressure—all major cardiovascular risk factors. Semaglutide also directly lowers inflammation and enhances endothelial function, both of which promote heart health. Wegovy can help you lose weight and improve your cardiovascular health over time when combined with lifestyle modifications like diet and exercise.
Indeed, Wegovy's effects on cardiovascular events and weight loss efficacy have been examined in the STEP and SELECT studies. In people who are overweight or obese, the SELECT study showed a significant decrease in major adverse cardiovascular events (MACE), including heart attacks, strokes, and cardiovascular deaths.
After beginning Wegovy, weight, blood pressure, and cholesterol levels can all improve in a matter of weeks to months. Multi-year trials like SELECT have demonstrated that reductions in cardiovascular risks, such as heart attacks or strokes, may become apparent over longer time periods. Nevertheless, since each person is unique, outcomes from certain trials and control groups may not always be replicated. You should see favorable outcomes if you keep your drug regimen regular and concentrate on your food and exercise.
Systolic and diastolic blood pressure are substantially decreased by Wegovy. In order to further improve cardiovascular and weight-related benefits, weight loss is primarily achieved by lowering the burden on the heart and improving vascular resistance by regular medication administration and suitable lifestyle modifications. By acting on GLP-1 receptors, semaglutide also promotes vasodilation, which lowers blood pressure. Clinical research has demonstrated that even slight weight loss with Wegovy is linked to quantifiable improvements in hypertension. Wegovy is an appealing option for people with high blood pressure and obesity because of these two benefits. Lower blood pressure improves cardiovascular health overall by lowering the risk of cardiovascular events including heart attacks and strokes.
Wegovy has a favorable effect on cholesterol levels, helping lower LDL cholesterol and triglycerides while slightly raising HDL cholesterol. These changes are crucial for reducing the risk of atherosclerosis, a condition where plaque buildup narrows arteries and increases the risk of cardiovascular events. Weight loss achieved with Wegovy reduces lipid accumulation in the liver and improves lipid metabolism.
Wegovy has a positive impact on cholesterol levels, assisting in the reduction of triglycerides and LDL cholesterol while somewhat increasing HDL cholesterol. Atherosclerosis, a disorder where plaque accumulation narrows arteries and raises the risk of cardiovascular events, can be prevented with these modifications. Wegovy-induced weight loss enhances lipid metabolism and decreases hepatic lipid buildup.
In recent news, weight loss jabs containing GLP-1 receptor agonists have been proven to reduce the risk of obesity-related cancer.
A clinical trialconducted by Clalit Health Services included 6356 adults who were being treated for obesity and type 2 diabetes. Half of the test group were given bariatric surgery while the other received first-generation weight loss injectables, like liraglutide, exenatide or dulaglutide. After a follow-up that took place over 7.5 years, 298 patients had been diagnosed with weight-related cancer in both control groups.
After weight loss from the surgery had been factored in, the study found that weight loss injections were 41% better at preventing obesity-linked cancers than bariatric surgery, which was 38%. Through combining this data, researchers have concluded that the use of GLP-1s alone can cut the risk of cancer by half.
Wegovy 7.2 mg is the highest strength of semaglutide currently available for weight management treatment.
It may be considered for people who have already progressed through the standard Wegovy dosing schedule and are currently taking the 2.4 mg maintenance dose but may benefit from additional appetite support.
The 7.2 mg strength was studied in clinical trials to assess whether a higher dose could support further weight reduction in some patients compared with the previously available maximum dose of 2.4 mg. Where the 2.4mg pen had shown an average of 17% of body weight lose over at 72-week period of treatment, the Wegovy 7.2mg strength showed an increased average of 21% of body weight lost over time.
Your prescriber will review your progress, weight-loss goals and how well you tolerate the medication before deciding whether the 7.2 mg dose is appropriate for you.
At present, the 7.2 mg dose is provided using three 2.4 mg injections taken during the same weekly dosing session.
This is because a single 7.2 mg injection pen is not yet widely available. Instead, the weekly dose is made up by administering three 2.4 mg doses at the same time.
Each 2.4 mg pen contains four weekly doses. Your prescriber or pharmacy will provide the appropriate number of pens so that you can take your full weekly treatment.
A dedicated 7.2 mg pen is expected to become available in the future.
The 7.2 mg dose may be considered for people who:
Your prescriber will assess your progress and overall health before recommending a higher dose.
Because the increase from 2.4 mg to 7.2 mg is significant, your healthcare professional will also discuss monitoring for possible side effects and ensuring the treatment remains suitable for you.
In some cases, a prescriber may review your progress on the 2.4 mg maintenance dose and consider increasing the dose if further weight-loss support may be beneficial.
If weight loss has slowed or appetite control has changed while remaining on the same dose, moving to a higher dose may be discussed as part of your treatment plan.
Any dose increase should only be made under the guidance of a qualified healthcare professional.
Yes. Wegovy 7.2 mg is still taken once per week, just like the other Wegovy doses.
When the dose is made up using 2.4 mg pens, the three injections are administered during the same weekly dosing session.
Clinical research has investigated whether higher doses of semaglutide could support additional weight loss in some patients.
In the STEP UP clinical trial, participants taking 7.2 mg of semaglutide once weekly lost an average of around 21% of their starting body weight over 72 weeks when the medication was combined with lifestyle changes such as a reduced-calorie diet and increased physical activity.
For comparison:
However, results vary between individuals, and medication works best when used alongside healthy lifestyle habits.
The types of side effects reported with the 7.2 mg dose are generally similar to those seen with lower Wegovy doses.
The most commonly reported side effects include:
These symptoms are often temporary and may improve as your body adjusts to treatment.
Because the 7.2 mg dose is higher, digestive side effects may occur more frequently in some people. In clinical trials, a slightly greater proportion of patients reported gastrointestinal symptoms compared with those taking the 2.4 mg dose.
If side effects become severe or persistent, you should contact your prescriber for advice.
No. Treatment with Wegovy normally begins at a starting dose of 0.25 mg once weekly, which is gradually increased over time.
This step-by-step dosing schedule allows your body to adjust to the medication and helps reduce the likelihood of side effects before reaching higher doses such as 7.2 mg.
Reaching the 7.2 mg dose can take several months.
Wegovy is usually increased gradually through the dosing schedule, starting at 0.25 mg and increasing approximately every four weeks until the most suitable maintenance dose is reached.
The full journey to the highest dose can take around 5–6 months or longer, depending on your progress and how well you tolerate each stage of treatment.
Your prescriber will review your progress at each stage to make sure the medication remains safe and effective.
If you miss a dose of Wegovy 7.2 mg, you should follow the instructions provided in the patient information leaflet or speak to your prescriber for guidance.
In many cases, if the missed dose is remembered within a few days, it can still be taken. If more time has passed, you may need to skip the missed dose and continue with your next scheduled injection.
Yes. Wegovy is designed to support weight loss alongside healthy lifestyle changes.
Following a balanced, reduced-calorie diet and staying physically active can help improve weight-loss outcomes while using the medication.
No. Wegovy may not be suitable for everyone.
Certain medical conditions, medications or health factors may affect whether this treatment is appropriate for you.
Your prescriber will review your medical history during your consultation to determine whether Wegovy is safe and suitable for your circumstances.
If side effects occur while taking the 7.2 mg dose, your prescriber may review your treatment plan and decide whether adjusting the dose is appropriate.
You should not change your dose without medical guidance.
Yes. At present, 7.2 mg is the highest Wegovy dose available for weight management treatment.
It may be considered when lower doses have already been used and additional appetite control or weight-loss support may be beneficial.
Yes. Wegovy is a prescription-only medicine in the UK.
A consultation with a qualified prescriber is required before treatment can be supplied.
Your prescriber will review your medical history, current medications and weight-management goals before recommending the most appropriate treatment plan.
Weight loss Injections are used for weight management in adults having obesity with medical complications such as Type 2 Diabetes, hypertension etc. You can find Wegovy in stock at Pharmacy Planet and get it delivered at your doorstep.
You can buy Wegovy injections online, starting from as low as £80 in the UK. Complete the simple online consultation form, which will be reviewed by our prescribing team to ensure you are eligible for using Wegovy in your weight loss journey.
The cost of Wegovy can vary based on strength and package sizes. If you are using wegovy for the first time, it is advised to start with the lowest Wegovy dosage 0.25mg per week and then gradually increase the dose each month in consultation with your clinician.
Wegovy Dosage:
The price list of Wegovy with multiple doses are as follows :
Starter Dose:
Wegovy 0.25 mg - £75 per month
Intermediate Doses:
Wegovy 0.5 mg - £95 per month
Wegovy 1.0 mg - £108 per month
Wegovy 1.7 mg - £125 per month
Wegovy 2.4 mg - £145 per month
Highest dose
Wegovy 7.2 mg (2.4mg x 3 pens) - £225
The Wegovy 7.2mg is still currently being reviewed for approval by the European Medicines Agency. This reviewing process can take a number of months, meaning that this new strength of Wegovy made by Novo Nordisk will probably not be released until late 2025 or early 2026.
You can move up to the Wegovy 7.2mg strength once you have reached the 2.4mg strength and feel like the level of weight loss is no longer adequate. This can be assessed by your clinician to ensure that moving up to this dose is safe for you. You should not take the Wegovy 7.2mg dose if you have a history of severe gastrointestinal issues on the lower doses, certain pre-existing medical conditions, or if you have not followed the dosing regimen from 0.25mg upwards.
Once Novo Nordisk is able to launch the new Wegovy strength of 7.2mg, you will be able to buy Wegovy 7.2mg online in the UK via Pharmacy Planet. As long as you have had your previous strengths and no medical difficulty, our clinical team should be able to issue you with this exciting new step in your weight loss journey.
Wegovy® is popular brand of weight loss medicine. It contains Semaglutide, which is an active ingredient in Wegovy. This is used to treat Type 2 diabetes but also helps in weight loss treatment in patients suffering from obesity with a BMI higher than 30 or a BMI of 27 and over for anyone with weight related health conditions such as hypertension or type 2 diabetes. It is most effective when used alongside a balanced diet and physical exercise over a long period of time.
Wegovy prescription medication is usually recommended for individuals:
IIf you are looking to buy Wegovy online in the UK, you would require valid prescription provided by health care professionals. You can start taking an online consultation and answering the clinical questionnaire which will be evaluated by our prescribers to make sure you qualify for this weight loss treatment.
Wegovy (Semaglutide) acts a natural hormone - glucagon-like peptide-1 (GLP 1) targets certain areas in the brain which control the appetite and blood sugar levels in your body. It gives you a feeling of fullness and reduces food cravings resulting in reduced intake of food leading to weight loss. It is a prefilled injectable pen with 4 doses, with one dose once weekly for 4 weeks, lasting for one month of treatment.
If you are taking Wegovy for first time, you often experience changes in appetite and noticeable weight loss within the first few weeks. Studies show that an average body weight reduction of 5% within a month. Usually, the weight loss with Wegovy is steady and some may achieve significant weight loss depending on age, dosage, etc
Following the regular wegovy dosage plan is necessary to ensure medication is taken consistently to achieve effective weight loss and minimising the side effects. Starting with a lower dose of 0.25 mg for the first 4 weeks helps your body adjust with the medication. After this initial period, the dose can be increased to 0.5 mg per week or higher, depending on your response to the treatment. It would take 4 to 5 weeks to reach a "steady state," where the drug concentration in your body remains consistent. It is advisable to consult your healthcare provider before increasing the doses.
Wegovy (semaglutide) should be injected under the skin once a week on the same day, at any time of the day, before or after food intake. The recommended wegovy dose for first time users is 0.25mg per week and must slowly increase over 20 weeks to maintain dose of 2.4 mg. This would help in minimizing the side effects. Each pen contains four doses lasting for a month.
Administering the injection: Hold the Wegovy pen at a 90-degree angle against the skin, ensuring it is firmly pressed against the injection site. Press the button to deliver the medication. The injection process may take a few seconds. Once complete, remove the pen from the skin.
By choosing fleshy areas of body such as upper arms, thighs or stomach (abdomen) can help the injection to hurt less. It is advised not to inject into your muscle or vein. It is better to shift injection sites to minimize discomfort and ensure optimal absorption.
If you're still struggling to figure out where you should inject, it is better to divide the injection site into four separate sections. For each dosage you can pick one of the sections and rotate between them until all four injections have been used. Also, if you are injecting in a similar spot on the upper arm or thigh, you can insert the wegovy pen at least one finger width away from your previous injection site.
Like any medications using Wegovy causes side effects that often happens within the gastro-intestinal tract. These include nausea, Diarrhoea, Vomiting, Constipation etc. Other mild side effects can be headaches, abdominal pain, tiredness, heartburn, sore throat etc. All these side effects should disappear within few weeks on its own. If it becomes severe, then consulting your doctor or pharmacist is important.
Serious side effects such as Low blood sugar levels (type 2 diabetes), Pancreatitis, Gall bladder problems, Diabetic eye problems, Risk of thyroid cancer, etc are reported in some cases.
Some patients have medical conditions which may not be suitable for using wegovy. Other factors may include cost, availability or side effects. Also, few may prefer oral medications over injections for weight loss treatments. You can explore the other treatment options provided below which would help you finding the right medication.
Mounjaro- Both Wegovy and Mounjaro are used for weight loss treatment in the UK. Mounjaro (Trizepatide) utilises dual action performance, as GLP 1 and GIP agonist are approved for type 2 diabetes management and weight loss alike.
Ozempic– The active ingredient in Wegovy, Semaglutide, is also found in Ozempic which controls the appetite and makes you feel satiety. The main difference is Wegovy has been officially licensed for weight loss while Ozempic is approved only for type 2 diabetes patients to manage their blood glucose levels.
Saxenda– Wegovy and Saxenda are injectable pens have similar functions and side effects. But the key difference are active ingredient, frequency of dosages, etc
Orlistat- It is available in form of capsules which absorbs up to 33% less fat from your diet aiding in weight loss for obese patients.
It is common that with obesity, the body faces a number of knock-on effects from this one condition. One of these, and arguably the most detrimental, is cardiovascular health. Patients who are overweight or obese have an increased risk of heart-related issues, like heart attacks, strokes and are at risk of dying early.
Wegovy encourages weight loss, which lowers blood sugar, LDL cholesterol, and high blood pressure—all major cardiovascular risk factors. Semaglutide also directly lowers inflammation and enhances endothelial function, both of which promote heart health. Wegovy can help you lose weight and improve your cardiovascular health over time when combined with lifestyle modifications like diet and exercise.
Indeed, Wegovy's effects on cardiovascular events and weight loss efficacy have been examined in the STEP and SELECT studies. In people who are overweight or obese, the SELECT study showed a significant decrease in major adverse cardiovascular events (MACE), including heart attacks, strokes, and cardiovascular deaths.
After beginning Wegovy, weight, blood pressure, and cholesterol levels can all improve in a matter of weeks to months. Multi-year trials like SELECT have demonstrated that reductions in cardiovascular risks, such as heart attacks or strokes, may become apparent over longer time periods. Nevertheless, since each person is unique, outcomes from certain trials and control groups may not always be replicated. You should see favorable outcomes if you keep your drug regimen regular and concentrate on your food and exercise.
Systolic and diastolic blood pressure are substantially decreased by Wegovy. In order to further improve cardiovascular and weight-related benefits, weight loss is primarily achieved by lowering the burden on the heart and improving vascular resistance by regular medication administration and suitable lifestyle modifications. By acting on GLP-1 receptors, semaglutide also promotes vasodilation, which lowers blood pressure. Clinical research has demonstrated that even slight weight loss with Wegovy is linked to quantifiable improvements in hypertension. Wegovy is an appealing option for people with high blood pressure and obesity because of these two benefits. Lower blood pressure improves cardiovascular health overall by lowering the risk of cardiovascular events including heart attacks and strokes.
Wegovy has a favorable effect on cholesterol levels, helping lower LDL cholesterol and triglycerides while slightly raising HDL cholesterol. These changes are crucial for reducing the risk of atherosclerosis, a condition where plaque buildup narrows arteries and increases the risk of cardiovascular events. Weight loss achieved with Wegovy reduces lipid accumulation in the liver and improves lipid metabolism.
Wegovy has a positive impact on cholesterol levels, assisting in the reduction of triglycerides and LDL cholesterol while somewhat increasing HDL cholesterol. Atherosclerosis, a disorder where plaque accumulation narrows arteries and raises the risk of cardiovascular events, can be prevented with these modifications. Wegovy-induced weight loss enhances lipid metabolism and decreases hepatic lipid buildup.
It is common that with obesity, the body faces a number of knock-on effects from this one condition. One of these, and arguably the most detrimental, is cardiovascular health. Patients who are overweight or obese have an increased risk of heart-related issues, like heart attacks, strokes and are at risk of dying early.
Wegovy encourages weight loss, which lowers blood sugar, LDL cholesterol, and high blood pressure—all major cardiovascular risk factors. Semaglutide also directly lowers inflammation and enhances endothelial function, both of which promote heart health. Wegovy can help you lose weight and improve your cardiovascular health over time when combined with lifestyle modifications like diet and exercise.
Indeed, Wegovy's effects on cardiovascular events and weight loss efficacy have been examined in the STEP and SELECT studies. In people who are overweight or obese, the SELECT study showed a significant decrease in major adverse cardiovascular events (MACE), including heart attacks, strokes, and cardiovascular deaths.
After beginning Wegovy, weight, blood pressure, and cholesterol levels can all improve in a matter of weeks to months. Multi-year trials like SELECT have demonstrated that reductions in cardiovascular risks, such as heart attacks or strokes, may become apparent over longer time periods. Nevertheless, since each person is unique, outcomes from certain trials and control groups may not always be replicated. You should see favorable outcomes if you keep your drug regimen regular and concentrate on your food and exercise.
Systolic and diastolic blood pressure are substantially decreased by Wegovy. In order to further improve cardiovascular and weight-related benefits, weight loss is primarily achieved by lowering the burden on the heart and improving vascular resistance by regular medication administration and suitable lifestyle modifications. By acting on GLP-1 receptors, semaglutide also promotes vasodilation, which lowers blood pressure. Clinical research has demonstrated that even slight weight loss with Wegovy is linked to quantifiable improvements in hypertension. Wegovy is an appealing option for people with high blood pressure and obesity because of these two benefits. Lower blood pressure improves cardiovascular health overall by lowering the risk of cardiovascular events including heart attacks and strokes.
Wegovy has a favorable effect on cholesterol levels, helping lower LDL cholesterol and triglycerides while slightly raising HDL cholesterol. These changes are crucial for reducing the risk of atherosclerosis, a condition where plaque buildup narrows arteries and increases the risk of cardiovascular events. Weight loss achieved with Wegovy reduces lipid accumulation in the liver and improves lipid metabolism.
Wegovy has a positive impact on cholesterol levels, assisting in the reduction of triglycerides and LDL cholesterol while somewhat increasing HDL cholesterol. Atherosclerosis, a disorder where plaque accumulation narrows arteries and raises the risk of cardiovascular events, can be prevented with these modifications. Wegovy-induced weight loss enhances lipid metabolism and decreases hepatic lipid buildup.
Wegovy 7.2 mg is the highest strength of semaglutide currently available for weight management treatment.
It may be considered for people who have already progressed through the standard Wegovy dosing schedule and are currently taking the 2.4 mg maintenance dose but may benefit from additional appetite support.
The 7.2 mg strength was studied in clinical trials to assess whether a higher dose could support further weight reduction in some patients compared with the previously available maximum dose of 2.4 mg. Where the 2.4mg pen had shown an average of 17% of body weight lose over at 72-week period of treatment, the Wegovy 7.2mg strength showed an increased average of 21% of body weight lost over time.
Your prescriber will review your progress, weight-loss goals and how well you tolerate the medication before deciding whether the 7.2 mg dose is appropriate for you.
The 7.2 mg dose may be considered for people who:
Your prescriber will assess your progress and overall health before recommending a higher dose.
Because the increase from 2.4 mg to 7.2 mg is significant, your healthcare professional will also discuss monitoring for possible side effects and ensuring the treatment remains suitable for you.
The 7.2 mg dose may be considered for people who:
In some cases, a prescriber may review your progress on the 2.4 mg maintenance dose and consider increasing the dose if further weight-loss support may be beneficial.
If weight loss has slowed or appetite control has changed while remaining on the same dose, moving to a higher dose may be discussed as part of your treatment plan.
Any dose increase should only be made under the guidance of a qualified healthcare professional.
Yes. Wegovy 7.2 mg is still taken once per week, just like the other Wegovy doses.
When the dose is made up using 2.4 mg pens, the three injections are administered during the same weekly dosing session.
Clinical research has investigated whether higher doses of semaglutide could support additional weight loss in some patients.
In the STEP UP clinical trial, participants taking 7.2 mg of semaglutide once weekly lost an average of around 21% of their starting body weight over 72 weeks when the medication was combined with lifestyle changes such as a reduced-calorie diet and increased physical activity.
For comparison:
However, results vary between individuals, and medication works best when used alongside healthy lifestyle habits.
The types of side effects reported with the 7.2 mg dose are generally similar to those seen with lower Wegovy doses.
The most commonly reported side effects include:
These symptoms are often temporary and may improve as your body adjusts to treatment.
Because the 7.2 mg dose is higher, digestive side effects may occur more frequently in some people. In clinical trials, a slightly greater proportion of patients reported gastrointestinal symptoms compared with those taking the 2.4 mg dose.
If side effects become severe or persistent, you should contact your prescriber for advice.
No. Treatment with Wegovy normally begins at a starting dose of 0.25 mg once weekly, which is gradually increased over time.
This step-by-step dosing schedule allows your body to adjust to the medication and helps reduce the likelihood of side effects before reaching higher doses such as 7.2 mg.
If you miss a dose of Wegovy 7.2 mg, you should follow the instructions provided in the patient information leaflet or speak to your prescriber for guidance.
In many cases, if the missed dose is remembered within a few days, it can still be taken. If more time has passed, you may need to skip the missed dose and continue with your next scheduled injection.
If you miss a dose of Wegovy 7.2 mg, you should follow the instructions provided in the patient information leaflet or speak to your prescriber for guidance.
In many cases, if the missed dose is remembered within a few days, it can still be taken. If more time has passed, you may need to skip the missed dose and continue with your next scheduled injection.
Yes. Wegovy is designed to support weight loss alongside healthy lifestyle changes.
Following a balanced, reduced-calorie diet and staying physically active can help improve weight-loss outcomes while using the medication.
No. Wegovy may not be suitable for everyone.
Certain medical conditions, medications or health factors may affect whether this treatment is appropriate for you.
Your prescriber will review your medical history during your consultation to determine whether Wegovy is safe and suitable for your circumstances.
If side effects occur while taking the 7.2 mg dose, your prescriber may review your treatment plan and decide whether adjusting the dose is appropriate.
You should not change your dose without medical guidance.
Yes. At present, 7.2 mg is the highest Wegovy dose available for weight management treatment.
It may be considered when lower doses have already been used and additional appetite control or weight-loss support may be beneficial.
Yes. Wegovy is a prescription-only medicine in the UK.
A consultation with a qualified prescriber is required before treatment can be supplied.
Your prescriber will review your medical history, current medications and weight-management goals before recommending the most appropriate treatment plan.
|
|
|
|
|
*% of people losing more than 5% of body weight.
If you're not losing weight on Wegovy after six months, there could be several factors that might be affecting your weight loss progress. Wegovy may not be effective if you eat high-calorie foods such as desserts, sweets, fast foods, etc. poor hydration, lack of exercise, and inadequate sleep. Adjusting your diet with more vegetables and low-calorie foods, exercising regularly, and taking the medication consistently will help you reduce weight. If you have any underlying medical conditions like hypothyroidism or type 2 diabetes then it is advised to consult your healthcare physician for further assistance.
Yes, Wegovy (semaglutide) is one of the approved weight loss medications, alongside Saxenda and Orlistat. It is a weekly injectable prescription-only medication recommended for those with a BMI above 30, or 27 for those with weight-related conditions like hypertension. Wegovy is very effective when used along with a reduced-calorie diet and regular physical exercise provider.
Wegovy and Ozempic are both prescription medications exist under different brand names that contain the same active ingredient, semaglutide. The key difference is Wegovy is specifically approved for weight loss and is used in weight management for obesity, while Ozempic is licensed to treat type 2 diabetes because it effectively controls blood sugar levels.
Yes, Wegovy can be taken when it is cold. After opening, it should be kept inside the refrigerator between 2°C to 8°C. Avoid placing it in the direct sunlight and above 30°C. Make sure you use the Wegovy Pen within 6 weeks from the date of opening.
Yes, in some cases, weight regain can occur after you stop taking Wegovy as your appetite is expected to return to normal within a week. However, certain metabolic benefits, such as improved blood sugar control, may still be retained in the body. To maintain the weight loss achieved during treatment, it's essential to follow a healthy diet and engage in regular physical exercise.
You must not take Wegovy if:
If you started taking wegovy (Semaglutide), you can expect losing up to 5% of your body weight in the first month. Some may experience immediate results of losing 2 pounds of weight per week which is around 8 pounds in a month. In Clinical trials it has been found that patients can lose 15% of their body weight with long term use i.e. over a year with lifestyle interventions. The results of weight loss differs between individuals depending on several factors such as medication dosage, age, diet, exercise etc.
ou can buy Wegovy weight loss injections online from Pharmacy Planet by filling out a clinical consultation questionnaire available on our website. Our in-house team of prescribers will assess your responses and prescribe you the medication if it is suitable for you.
Ozempic: Hollywoods Favourite Weight Loss Drug
Everything You Need To Know About Wegovy
Wegovy vs. Other Weight Loss Solutions
When Will Wegovy Be Available? Exploring Prices and Cost Effectiveness
Wegovy Weight Loss Results: How Much Weight Can You Expect To Lose?
Mastering The Art Of Injecting Wegovy: Tips, Techniques, And Key Differences From Ozempic
The Truth About Wegovy And That Side Effect
Wegovy And Emotional Well-Being: The Psychological Impact Of Weight Loss
Please read the important safety precautions carefully and other info about Wegovy provided in the patient information leaflet. This can be found in the medication box, or you can use the link provided for a digital copy.
Answer a few questions on your health and your fitness goals.
Our clinicians will review your clinical questionnaire to make sure treatment is right for you.
Once approved, you will access our wealth of experience and resources curated by our team and begin your clinical weight loss journey.
Start your weight loss journey heading in the right direction. Our team are here to help. Whether you’re unsure about which medicine is right for you or need help navigating the world of weight loss drugs, our team are on hand to help you make the right decision. We can put you in touch with one of our experienced weight loss clinicians so you can be sure you’re making the best decision with the most accurate information.
To get in touch, contact our Customer Service team on 0800 978 8956 or email [email protected].
Authored By
HARMINDER ‘HARMY’ KAUR
BSc(hons) Pharmacy
GPhC Number: 2061107
Reviewed By
GURDEV SEHMI
BSc Pharm, MRPharmS, Independent Prescriber, Superintendent Pharmacist, Clinical Lead
GPhC Number: 2050925
My Weight Loss Journey with Pharmacy Planet. My name is Michelle, and for as long as I can remember, my weight has been something I struggled with. It affected my confidence, my health, and my overall well-being. I had tried countless diets, exercise ...
My name is Natalie, and for most of my adult life, I’ve struggled with my weight. I’ve tried everything you can imagine—Weight Watchers, Slimming World, calorie counting, Atkins, and even the Cambridge Diet. Some worked for a short time, but nothing ever .....
My name is Linda, and my weight loss journey has been a long and difficult one. I have struggled for years, trying various methods, from Weight Watchers to calorie counting and even gym memberships. Unfortunately, none of these ever provided ....
My Weight Loss Journey with Wegovy and Pharmacy Planet. Losing weight has never been an easy feat for me. I tried all options I had available which were the usual contenders—personal trainers healthy eating, and even strict calorie counting. After all my best ...
For years, trying to lose weight felt impossible. As a woman over 35 navigating losing weight in perimenopause, I’d tried everything—strict diets, intense workouts, even weight loss massages—but nothing worked. Finding it difficult to lose weight became ....
the items you wish to order
by our qualified prescriber
to your door step
